title: Protein replacement therapy partially corrects the cholesterol-storage phenotype in a mouse model of Niemann-Pick type C2 disease.
abstract: Niemann-Pick type C2 (NPC2) disease is a fatal autosomal recessive neurovisceral degenerative disorder characterized by late endosomal-lysosomal sequestration of low-density lipoprotein derived cholesterol. The breach in intracellular cholesterol homeostasis is caused by deficiency of functional NPC2, a soluble sterol binding protein targeted to the lysosomes by binding the mannose-6-phosphate receptor. As currently there is no effective treatment for the disorder, we have investigated the efficacy of NPC2 replacement therapy in a murine gene-trap model of NPC2-disease generated on the 129P2/OlaHsd genetic background. NPC2 was purified from bovine milk and its functional competence assured in NPC2-deficient fibroblasts using the specific cholesterol fluorescent probe filipin. For evaluation of phenotype correction in vivo, three-week-old NPC2(-/-) mice received two weekly intravenous injections of 5 mg/kg NPC2 until trial termination 66 days later. Whereas the saline treated NPC2(-/-) mice exhibited massive visceral cholesterol storage as compared to their wild-type littermates, administration of NPC2 caused a marked reduction in cholesterol build up. The histological findings, indicating an amelioration of the disease pathology in liver, spleen, and lungs, corroborated the biochemical results. Little or no difference in the overall cholesterol levels was observed in the kidneys, blood, cerebral cortex and hippocampus when comparing NPC2(-/-) and wild type mice. However, cerebellum cholesterol was increased about two fold in NPC2(-/-) mice compared with wild-type littermates. Weight gain performance was slightly improved as a result of the NPC2 treatment but significant motor coordination deficits were still observed. Accordingly, ultrastructural cerebellar abnormalities were detected in both saline treated and NPC2 treated NPC2(-/-) animals 87 days post partum. Our data indicate that protein replacement may be a beneficial therapeutic approach in the treatment of the visceral manifestations in NPC2 disease and further suggest that neurodegeneration is not secondary to visceral dysfunction.
authors.affiliation: Department of Molecular Biology, Aarhus University, Aarhus, Denmark. cwh@mb.au.dk
authors.forename: Gitte Krogh
authors.initials: GK
authors.lastname: Nielsen
authors.forename: Frederik
authors.initials: F
authors.lastname: Dagnaes-Hansen
authors.forename: Ida Elisabeth
authors.initials: IE
authors.lastname: Holm
authors.forename: Steve
authors.initials: S
authors.lastname: Meaney
authors.forename: Derek
authors.initials: D
authors.lastname: Symula
authors.forename: Niels Trolle
authors.initials: NT
authors.lastname: Andersen
authors.forename: Christian Würtz
authors.initials: CW
authors.lastname: Heegaard
mesh_terms: D000818:Animals; D001483:Base Sequence; D002352:Carrier Proteins / Q000235:genetics / Q000627:therapeutic use*; D002478:Cells, Cultured; D017931:DNA Primers; D004195:Disease Models, Animal; D005456:Fluorescent Dyes; D006023:Glycoproteins / Q000235:genetics / Q000627:therapeutic use*; D006801:Humans; D007150:Immunohistochemistry; D051379:Mice; D018345:Mice, Knockout; D052556:Niemann-Pick Disease, Type C / Q000628:therapy*; D010641:Phenotype; D016133:Polymerase Chain Reaction; D033921:Vesicular Transport Proteins
chemical_list: D002352:Carrier Proteins; D017931:DNA Primers; D005456:Fluorescent Dyes; D006023:Glycoproteins; C104585:NPC2 protein, human; D033921:Vesicular Transport Proteins
references.citation: J Biol Chem. 2011 Jan 21;286(3):2078-87
references.pmid: 21084287
references.citation: J Lipid Res. 2010 May;51(5):933-44
references.pmid: 19965601
references.citation: Hepatology. 2006 Jan;43(1):126-33
references.pmid: 16374838
references.citation: J Exp Med. 2007 Apr 16;204(4):841-52
references.pmid: 17389239
references.citation: Mol Ther. 2008 Jul;16(7):1261-6
references.pmid: 18443601
references.citation: Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2377-82
references.pmid: 19171898
references.citation: Lancet Neurol. 2007 Sep;6(9):765-72
references.pmid: 17689147
references.citation: J Neuropathol Exp Neurol. 2000 Dec;59(12):1106-17
references.pmid: 11138930
references.citation: Biol Reprod. 1996 Apr;54(4):847-56
references.pmid: 8924505
references.citation: Eur J Biochem. 1997 Jan 15;243(1-2):437-41
references.pmid: 9030770
references.citation: Hum Mol Genet. 2010 Mar 1;19(5):837-47
references.pmid: 20007718
references.citation: Science. 1968 Nov 1;162(3853):570-2
references.pmid: 4236721
references.citation: Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):5886-91
references.pmid: 15071184
references.citation: Clin Genet. 2007 Apr;71(4):320-30
references.pmid: 17470133
references.citation: Hepatology. 2005 Oct;42(4):886-93
references.pmid: 16175610
references.citation: Neurochem Res. 1999 Apr;24(4):481-9
references.pmid: 10227680
references.citation: Orphanet J Rare Dis. 2010 Jun 03;5:16
references.pmid: 20525256
references.citation: J Child Neurol. 2010 Mar;25(3):300-5
references.pmid: 19822772
references.citation: Clin Genet. 2010 Feb;77(2):119-30
references.pmid: 20002450
references.citation: Biochim Biophys Acta. 2009 Jul;1791(7):671-8
references.pmid: 19232397
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12873-8
references.pmid: 17646643
references.citation: J Lipid Res. 2010 Aug;51(8):2372-83
references.pmid: 20418540
references.citation: J Biol Chem. 1957 May;226(1):497-509
references.pmid: 13428781
references.citation: Chest. 2007 Oct;132(4):1311-21
references.pmid: 17934117
references.citation: Mol Genet Metab. 1999 Jul;67(3):194-205
references.pmid: 10381327
references.citation: Mol Ther. 2008 Apr;16(4):649-56
references.pmid: 18362923
references.citation: IUBMB Life. 2010 Jan;62(1):33-40
references.pmid: 20014233
references.citation: Stem Cells. 2006 Jun;24(6):1549-55
references.pmid: 16484344
references.citation: Brain. 2007 Jan;130(Pt 1):120-33
references.pmid: 17003072
references.citation: J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S171-3
references.pmid: 20393800
references.citation: PLoS One. 2009 Sep 11;4(9):e6951
references.pmid: 19750228
references.citation: J Inherit Metab Dis. 2004;27(6):757-66
references.pmid: 15505381
references.citation: Curr Biol. 2001 Aug 21;11(16):1283-7
references.pmid: 11525744
references.citation: J Biol Chem. 2010 Sep 24;285(39):30347-54
references.pmid: 20650896
references.citation: Pediatr Ann. 2009 Aug;38(8):448-55
references.pmid: 19725195
references.citation: Pediatr Res. 2010 Oct;68(4):309-15
references.pmid: 20581737
references.citation: Arch Pediatr. 2005 Apr;12(4):434-7
references.pmid: 15808435
references.citation: Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5477-82
references.pmid: 20212119
references.citation: Science. 2000 Dec 22;290(5500):2298-301
references.pmid: 11125141
references.citation: J Biol Chem. 2010 Feb 12;285(7):4983-94
references.pmid: 20007703
references.citation: Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2512-7
references.pmid: 12591954
references.citation: Pediatr Crit Care Med. 2007 Sep;8(5):486-8
references.pmid: 17693917
references.citation: Gastroenterology. 2011 May;140(5):1664-74
references.pmid: 21315718
references.citation: Am J Med Genet A. 2011 Mar;155A(3):540-7
references.pmid: 21344635
references.citation: Brain Res. 1987 Apr;429(2):271-81
references.pmid: 3567665
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14777-82
references.pmid: 16162667
references.citation: FEBS Lett. 2010 Jul 2;584(13):2731-9
references.pmid: 20416299
references.citation: Neuropathol Appl Neurobiol. 1993 Apr;19(2):120-7
references.pmid: 8316332
references.citation: Med Sci Monit. 2008 Aug;14(8):CS71-5
references.pmid: 18668002
references.citation: Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12658-63
references.pmid: 15314220
references.citation: PLoS One. 2011 Jan 06;6(1):e15777
references.pmid: 21253586
references.citation: Brain Res. 2009 May 13;1270:140-51
references.pmid: 19328188
references.citation: Ann Neurol. 2005 Apr;57(4):542-8
references.pmid: 15786474
references.citation: J Biol Chem. 2007 Aug 10;282(32):23525-31
references.pmid: 17573352
references.citation: J Neuropathol Exp Neurol. 2001 Jan;60(1):49-64
references.pmid: 11202175
references.citation: Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15287-92
references.pmid: 18772377
references.citation: Drugs. 2007;67(18):2697-716
references.pmid: 18062719
references.citation: Neurology. 1989 Aug;39(8):1040-9
references.pmid: 2761697
references.citation: Science. 1997 Jul 11;277(5323):228-31
references.pmid: 9211849